Click here to answer our weekly poll.
Dermatology Times Staff
Advertisement
Articles by Dermatology Times Staff
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Join us in an upcoming webinar sponsored by Aerolase that provides the latest insight on how to grow your practice and profits beyond the COVID-19 pandemic.
More than 90% of respondents to a recent survey expressed concern about acne’s effect on their adolescent’s mental health and social life.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer out weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
A glimpse at what to expect from Dermatology Times this week.
Click here to answer our weekly poll.
Voltaire-X study data shows that switching several times between Cyltezo and Humira results in similar pharmacokinetics, efficacy, immunogenicity, and safety in people with moderate to severe chronic plaque psoriasis.
In phase 3b data presented at the American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2021 showed bimekizumab achieved superior levels of complete skin clearance compared to secukinumab for psoriasis.
A glimpse at what to expect from Dermatology Times this week.
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Reviewing Type 2 Inflammation Through a Different Lens
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5
